Incannex Healthcare Inc.
IXHL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873875
No open-market purchases or sales by Incannex Healthcare Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.71M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Incannex Healthcare Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 4 | 6 | +2 |
| Shares | 31.9K | 272.6K | +240.7K (+755.0%) |
| Value | $133.3K | $1.26M | +$1.13M (+848.6%) |
New holders (6)
Institutions that held Incannex Healthcare Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 114,051 | $529.2K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 81,747 | $379.3K | 0.00% |
| AdvisorShares Investments LLC | 38,757 | $179.8K | 0.04% |
| Millennium Management LLC | 21,733 | $100.8K | 0.00% |
| Citadel Advisors LLC | 13,725 | $63.7K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,598 | $12.1K | 0.00% |
Sold out (4)
Institutions that held Incannex Healthcare Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Bank of Montreal | 30,692 | $132.0K |
| Qube Research & Technologies Ltd | 1,059 | $1.22K |
| UBS Group AG | 79 | $90 |
| Rhumbline Advisers | 55 | $63 |